CJC-1295 Without DAC is a growth hormone-releasing hormone (GHRH) analogue studied for endocrine signaling and pulsatile growth hormone research. Its shorter activity profile makes it valuable for specialized laboratory investigations.

CJC-1295 Without DAC, GHRH Peptide, Research Peptide, Growth Hormone Research

Premium CJC-1295 Without DAC peptide for laboratory research involving GHRH signaling and endocrine pathways.

Disclaimer: Our peptides are research-grade products for laboratory use only. They are not approved for human consumption or medical use. Always follow proper laboratory safety protocols.

CJC-1295| Premium Research Peptide | The Peptide Labs Canada

Overview

CJC-1295 is a high-purity synthetic research peptide classified as a growth hormone-releasing hormone (GHRH) analog. It is widely investigated in endocrinology and metabolic research for its ability to stimulate endogenous growth hormone (GH) release through activation of GHRH receptors within the pituitary gland.

In controlled laboratory environments, CJC-1295 is studied for its prolonged activity profile, making it a valuable research tool for examining growth hormone secretion, endocrine signaling, and metabolic regulation over extended observation periods.

Growth Hormone and Endocrine Research

CJC-1295 is extensively investigated for its role in growth hormone regulation and pituitary function. Current laboratory research focuses on its involvement in:

• Endogenous growth hormone secretion
• Growth hormone-releasing hormone (GHRH) signaling
• Pituitary receptor activation
• Endocrine feedback mechanisms
• Hormonal regulation
• Metabolic signaling pathways

These experimental models help researchers better understand the physiological regulation of growth hormone and its downstream effects on metabolism and endocrine function.

Growth Hormone Pulse Dynamics

One of the distinguishing characteristics of CJC-1295 is its extended duration of activity compared with native GHRH.

Researchers frequently investigate its potential effects on:

• Growth hormone pulse frequency
• Growth hormone pulse amplitude
• Circadian hormone rhythms
• Endocrine signaling dynamics
• Hormonal feedback regulation
• Long-term growth hormone release patterns

These studies provide valuable insight into the mechanisms that regulate growth hormone secretion and endocrine homeostasis.

Pharmacokinetic and Metabolic Research

CJC-1295 has been structurally modified to provide enhanced stability and prolonged biological activity. Laboratory research evaluates its pharmacokinetic properties, including its interaction with albumin and resistance to rapid enzymatic degradation.

Researchers continue to investigate:

• Peptide pharmacokinetics
• Albumin binding characteristics
• Receptor activation dynamics
• Cellular signaling pathways
• Metabolic adaptation
• Endocrine regulation

These investigations support long-term laboratory studies focused on growth hormone physiology and metabolic function.

Laboratory Formulation

CJC-1295 is supplied as a sterile, lyophilized (freeze-dried) powder to promote stability during storage and laboratory handling.

The format is well suited for:

• Dose-response studies
• Comparative peptide research
• Extended laboratory protocols
• Controlled in-vitro experiments

When properly reconstituted using established laboratory procedures, researchers can achieve consistent concentrations that support reproducible experimental outcomes.

Storage Recommendations

To preserve peptide integrity, CJC-1295 should be stored according to accepted laboratory handling practices.

• Store lyophilized vials under recommended laboratory conditions.
• After reconstitution with bacteriostatic water, refrigerate between 2°C and 8°C.
• Avoid repeated freeze-thaw cycles and prolonged exposure to heat or direct light.
• Proper storage helps maintain peptide stability throughout the duration of research studies.

Analytical testing, including HPLC verification, is recommended to confirm product purity and batch consistency for laboratory applications.

Key Research Features

• Synthetic growth hormone-releasing hormone (GHRH) analog
• Investigated in growth hormone and endocrine research
• Studied for prolonged growth hormone release dynamics
• Explored in metabolic regulation and pituitary signaling models
• Examined in endocrine feedback and hormonal pathway research
• Sterile lyophilized powder for laboratory use
• Intended exclusively for in-vitro and research applications

Research Applications

CJC-1295 remains one of the most widely studied GHRH analogs in endocrine research due to its prolonged biological activity and well-characterized mechanism of action. It is frequently incorporated into laboratory studies investigating growth hormone regulation, endocrine physiology, metabolic signaling, and long-term hormonal adaptation.

Its extended activity profile and established role in growth hormone research make CJC-1295 a valuable addition to peptide libraries focused on advancing the understanding of endocrine function and metabolic biology.

Disclaimer

CJC-1295 is supplied for laboratory research use only. It is not intended for human or veterinary use, therapeutic applications, diagnosis, or consumption. All handling and use should comply with applicable laboratory regulations, institutional guidelines, and local laws governing research materials.